Pressmeddelande

BioStock: PK study in focus during Emplicure’s third quarter

Cision Publicerad: 25 Nov 2022 08:46

During Emplicure’s third quarter, the focus has been on the pharmacokinetic study with the company’s main project Empli03, which is aimed at patients with chronic pain. A new CEO was also appointed during the quarter and a holding company structure was implemented. BioStock talked to the company’s newly appointed CEO Håkan Engqvist about the past quarter.

Read the full article about Emplicure at biostock.se

https://www.biostock.se/en/2022/11/pk-study-in-focus-during-emplicures-third-quarter

This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se/en

Nyheter om Emplicure

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!